A detailed history of Virginia Wealth Management Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Virginia Wealth Management Group, Inc. holds 11,386 shares of AMGN stock, worth $3.63 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares
11,386
Previous 8,377 35.92%
Holding current value
$3.63 Million
Previous $2.62 Million 40.16%
% of portfolio
2.3%
Previous 2.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$309.38 - $337.38 $930,924 - $1.02 Million
3,009 Added 35.92%
11,386 $3.67 Million
Q2 2024

Jul 16, 2024

SELL
$262.75 - $319.31 $15,502 - $18,839
-59 Reduced 0.7%
8,377 $2.62 Million
Q1 2024

Apr 25, 2024

SELL
$268.87 - $324.56 $109,430 - $132,095
-407 Reduced 4.6%
8,436 $2.4 Million
Q4 2023

Feb 08, 2024

SELL
$255.7 - $288.46 $584,274 - $659,131
-2,285 Reduced 20.53%
8,843 $2.55 Million
Q3 2023

Nov 03, 2023

BUY
$218.65 - $271.46 $3,935 - $4,886
18 Added 0.16%
11,128 $2.99 Million
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $11,356 - $13,428
-53 Reduced 0.47%
11,110 $2.47 Million
Q1 2023

May 05, 2023

BUY
$225.79 - $275.2 $53,286 - $64,947
236 Added 2.16%
11,163 $2.7 Million
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $37,102 - $47,143
162 Added 1.5%
10,927 $2.87 Million
Q3 2022

Oct 19, 2022

SELL
$224.46 - $253.15 $87,090 - $98,222
-388 Reduced 3.48%
10,765 $2.43 Million
Q2 2022

Jan 04, 2023

SELL
$230.71 - $256.74 $402,358 - $447,754
-1,744 Reduced 16.2%
9,021 $2.2 Million
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $490,720 - $546,085
2,127 Added 23.57%
11,153 $2.71 Million
Q1 2022

Apr 20, 2022

BUY
$219.27 - $242.57 $156,558 - $173,194
714 Added 8.59%
9,026 $2.26 Million
Q4 2021

Jan 18, 2022

BUY
$198.88 - $227.6 $1.65 Million - $1.89 Million
8,312 New
8,312 $1.87 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Virginia Wealth Management Group, Inc. Portfolio

Follow Virginia Wealth Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Wealth Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virginia Wealth Management Group, Inc. with notifications on news.